Patent · US Active

Polypeptides derived from Enterococcus and their use for vaccination and the generation of therapeutic antibodies

US11278609B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignees

Klinikum der Universität München · DE
UNIVERSITE DE CAEN BASSE NORMANDIE · FR

Inventors

Johannes Hübner · Glückstadt, DE
Axel Hartke · Ouistreham, FR
Luis Felipe Romero Saavedra · Munich, DE

Key dates

Filing date	Feb 25, 2015
Grant date	Mar 22, 2022
Priority date	—
Expiry date	Feb 25, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/572
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Medicament for the treatment or the prevention of a bacterial infection, characterized in that it contains at least one polypeptide selected from the group of SEQ ID NO: 1 to SEQ ID NO: 9, and contiguous fragments thereof, wherein said at least one polypeptide or contiguous fragment thereof induces opsonic antibodies in a patient in need thereof. The polypeptides or the contiguous fragments thereof according to the present invention can be used for the preparation of a vaccine against an infection against Enterococcus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.